CY1116561T1 - ANTI-ALPHA2 INTEGRINE ANTIBODIES AND THEIR USES - Google Patents
ANTI-ALPHA2 INTEGRINE ANTIBODIES AND THEIR USESInfo
- Publication number
- CY1116561T1 CY1116561T1 CY20151100571T CY151100571T CY1116561T1 CY 1116561 T1 CY1116561 T1 CY 1116561T1 CY 20151100571 T CY20151100571 T CY 20151100571T CY 151100571 T CY151100571 T CY 151100571T CY 1116561 T1 CY1116561 T1 CY 1116561T1
- Authority
- CY
- Cyprus
- Prior art keywords
- antibodies
- integrin
- integrine
- alpha2
- bind
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Η εφεύρεση αναφέρεται σε αντισώματα αντι-α2 ιντεγκρίνης και στις χρήσεις τους. Περιγράφονται εξανθρωπισμένα αντισώματα, τα οποία προσδένονται στην I περιοχή της α2 ιντεγκρίνης και αναστέλλουν την αλληλεπίδραση της α2β1 ιντεγκρίνης με το κολλαγόνο. Περιγράφονται επίσης οι θεραπευτικές χρήσεις των αντισωμάτων αντι-α2 ιντεγκρίνης στην αντιμετώπιση των διαμεσολαβούμενων από την α2β1 διαταραχών, συμπεριλαμβανομένων των αντισωμάτων αντι-α2 ιντεγκρίνης που προσδένονται στην α2 ιντεγκρίνη χωρίς να ενεργοποιούνται τα αιμοπετάλια.The invention relates to anti-α2 integrin antibodies and their uses. Humanized antibodies are described, which bind to the α region of α2 integrin and inhibit the interaction of α2β1 integrin with collagen. Also described are therapeutic uses of anti-α2 integrin antibodies in the treatment of α2β1-mediated disorders, including anti-α2 integrin antibodies that bind to α2 integrin without activating platelets.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73830305A | 2005-11-18 | 2005-11-18 | |
EP06804739.8A EP1948798B1 (en) | 2005-11-18 | 2006-11-17 | Anti-alpha2 integrin antibodies and their uses |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1116561T1 true CY1116561T1 (en) | 2017-03-15 |
Family
ID=58459770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20151100571T CY1116561T1 (en) | 2005-11-18 | 2015-07-01 | ANTI-ALPHA2 INTEGRINE ANTIBODIES AND THEIR USES |
Country Status (1)
Country | Link |
---|---|
CY (1) | CY1116561T1 (en) |
-
2015
- 2015-07-01 CY CY20151100571T patent/CY1116561T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119454T1 (en) | ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA | |
CY1121162T1 (en) | M-CSF-SPECIAL MONOCLONIC ANTIBODY AND ITS USE | |
EA016245B9 (en) | Anti-alpha2 integrin antibodies and their uses | |
CY1119890T1 (en) | TREATMENT TREATMENT OF TREATMENT USING SPECIAL ANTI-ANTI-L1 | |
CY1116913T1 (en) | MODIFIED FAB Fragrances | |
CY1121672T1 (en) | ANTIBODIES THAT BIND IL-17A AND IL-17F | |
NL301089I2 (en) | imlifidase | |
CY1119751T1 (en) | MATERIALS AND METHODS FOR TREATMENT OR PREVENTION OF HER-3 DISEASES | |
CY1118979T1 (en) | ANTIBODIES DIRECTED AGAINST HER-3 AND USE OF THESE | |
CY1125025T1 (en) | 2-FORMYL-3-HYDROXYPHENYLOXIMETHYL COMPOUNDS CAPABLE OF ADJUSTING HEMOSPHERIN | |
CY1115700T1 (en) | ANTI-CD79B ANTIBODIES AND IMMUNIZATIONS AND METHODS OF USE | |
CY1108767T1 (en) | AREAS OF SYNTHETIC TREATMENT WITH MODIFIED BATHING PROPERTIES IN THE MORAL AREAS DIFFERENT AREAS | |
CY1116632T1 (en) | ANTIBODIES DETERMINATORS OF THE HUMAN RECOVERY STAGES | |
CY1122476T1 (en) | OPTIMIZED MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFRI) | |
ATE461220T1 (en) | ANTI-EGFR ANTIBODIES | |
CY1117302T1 (en) | ANTI-MIF ANTIBODIES | |
CY1119412T1 (en) | METHODS FOR EVALUATING AN IMMUNE RESPONSE TO A THERAPEUTIC FACTOR | |
CY1112798T1 (en) | DIARYLIDOIN COMPOUNDS | |
CY1115871T1 (en) | METHODS FOR TREATMENT OF URINARY ARTHRITIS | |
CY1113640T1 (en) | METHODS FOR TREATMENT OF Rheumatoid Arthritis | |
CY1110571T1 (en) | OPTIONAL MEDICAL VASCULAR OPTIONS-2 | |
CY1111194T1 (en) | OPTIONALLY ACCESSIBLE PEPPININYLI UNIVERSES | |
CY1124153T1 (en) | ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127 | |
CY1120424T1 (en) | HUMAN BATTERIES PROTECTED BY POLYNECTORS, POLYNUCLEOTICES CODING WITH THESE Peptides And Their | |
CY1118710T1 (en) | COMPOSITIONS FOR TREATMENT OF MULTIPLE SCIENCE |